Status:
ACTIVE_NOT_RECRUITING
COVID-19 Infection in Patients With Hepatocellular Carcinoma
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Collaborating Sponsors:
Centre Hospitalier-Universitaire Bondy
University Hospital, Bordeaux
Conditions:
Hepatocellular Carcinoma
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Since December 2019, a new disease named COVID-19 linked to a new coronavirus, SARS-CoV2 has emerged in China in the city of Wuhan, Hubei province, spreading very quickly to all 5 continents, and resp...
Eligibility Criteria
Inclusion
- Patients with CHC and included in the French national prospective cohort CHIEF
- Hospital and ambulatory patients
- Infection confirmed by COVID-19 defined by a positive nasopharyngeal PCR or if PCR COVID-19 negative : CT showing COVID-19 compatible pneumonia
- Suspected COVID-19 infection, not confirmed by COVID-19 PCR or chest CT, with no other known cause of acute pneumonia.
Exclusion
- Patient refusal
- Influenza only, confirmed by a diagnostic test
- Other proven causes of pneumonia and absence of COVID-19
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04367805
Start Date
April 27 2020
End Date
October 1 2024
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480